Novartis has now announced the price for gene therapy AVXS-101. Is it expected the cost 4 $ million – 5$ million per patient.
The next expensive treatment will be at some point a contention in our health system. Small countries like Denmark cannot afford the expensive medicine of Spinraza, what is then with this drug!
Although AVXS-101 is given once by single infusion, is the final price entitled!
Tell us what you think about this price. Share your thoughts below 👇